4
Changes in Ownership
Ernexa Therapeutics Inc. Filed Acc 0001019687-10-001063
CEO acquired 328,125 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bateman Terry Allan · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2010-03-19 | Exercise or conversion : show line 1 in the form | +328,125 | $0.17 | $55,781 | 503,958 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2010-03-19 | Exercise or conversion : show line 2 in the form Employee Stock Option (Right to Buy) | +328,125 | 1,276,042 | D |
Loading xslF345X03/edgar.xml…